Evaluation of disability in patients exposed to fluoroquinolones.

Marsha A Wilcox Angelina Villasis-Keever Anthony G Sena Christopher Knoll Daniel Fife

Published in: BMC pharmacology & toxicology (2020)

Comparative assessments are difficult to conduct in spontaneous reports. This examination of disability associated with adverse events in different system organ classes showed no difference between fluoroquinolones and azithromycin or sulfamethoxazole in administrative data.

Keyphrases

end stage renal disease
multiple sclerosis
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
emergency department
big data
electronic health record
machine learning
patient reported outcomes